FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1477711000001104: Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1879501000001112 Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1879521000001117 Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Is a Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free 100 ml true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Is pack of Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has AMP Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free (Kent Pharma (UK) Ltd) 100 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start